Anna Adam-Artigues

3PUBLICATIONS
34CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Nov 20, 2023
A PERK-Specific Inhibitor Blocks Metastatic Progression by Limiting Integrated Stress Response-Dependent Survival of Quiescent Cancer Cells.

Veronica Calvo, Wei Zheng, Anna Adam-Artigues

|May 20, 2022
Targeting HER2-AXL heterodimerization to overcome resistance to HER2 blockade in breast cancer.

Anna Adam-Artigues, Enrique J Arenas, Alex Martínez-Sabadell

|Aug 07, 2021
Oral Selective Estrogen Receptor Degraders (SERDs) as a Novel Breast Cancer Therapy: Present and Future from a Clinical Perspective.

Cristina Hernando, Belén Ortega-Morillo, Marta Tapia

Pageof 1